Cadrenal Financial Statements From 2010 to 2026

Cadrenal Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 7.1 M 11.6 M 2.8 M Slightly volatile Short and Long Term Debt Total 18.3 K 19.2 K 494.7 K Slightly volatile Other Current Liabilities 983.9 K 1.4 M 905.2 K Slightly volatile Total Current Liabilities 1.8 M 3.1 M 1.5 M Slightly volatile Other Liabilities 3.5 M 4 M 4.3 M Slightly volatile Property Plant And Equipment Net 5.9 K 6.2 K 36.6 K Slightly volatile Accounts Payable 1.8 M 1.7 M 616.2 K Slightly volatile Cash 6.8 M 11.5 M 2.2 M Slightly volatile Non Current Assets Total 9.2 K 9.7 K 42 K Slightly volatile Other Assets 4.8 K 5.4 K 5.9 K Slightly volatile Long Term Debt 442.7 K 498 K 543.6 K Slightly volatile Cash And Short Term Investments 6.8 M 11.5 M 2.2 M Slightly volatile Common Stock Shares Outstanding 1 M 1.4 M 860.2 K Slightly volatile Liabilities And Stockholders Equity 7.1 M 11.6 M 2.8 M Slightly volatile Other Current Assets 48.5 K 51 K 545.9 K Slightly volatile Other Stockholder Equity 20.9 M 38.1 M 7.6 M Slightly volatile Total Liabilities 2.6 M 2.4 M 5.3 M Slightly volatile Property Plant And Equipment Gross 5.9 K 6.2 K 36.6 K Slightly volatile Short and Long Term Debt 35 K 39.4 K 43 K Slightly volatile Total Current Assets 7.1 M 11.6 M 2.8 M Slightly volatile Capital Stock 1.5 K 1.6 K 7.3 K Slightly volatile Short Term Debt 34.9 K 19.2 K 56.2 K Slightly volatile Common Stock 1.5 K 1.6 K 7.3 K Slightly volatile Property Plant Equipment 35.7 K 40.1 K 43.8 K Slightly volatile Current Deferred Revenue 426.2 K 479.4 K 523.3 K Slightly volatile Net Receivables 30.5 K 34.3 K 37.5 K Slightly volatile
Cadrenal Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 1.9 K 2.2 K 1.4 K Slightly volatile Other Operating Expenses 7.8 M 12.6 M 4.4 M Slightly volatile Research Development 3.2 M 4.8 M 1.3 M Slightly volatile Cost Of Revenue 1.9 K 2.2 K 1.4 K Slightly volatile Total Operating Expenses 7.8 M 12.6 M 4.4 M Slightly volatile Net Interest Income 297.7 K 355.6 K 247.7 K Slightly volatile Interest Income 307.1 K 355.6 K 262.3 K Slightly volatile Selling General Administrative 5.7 M 7.8 M 4.1 M Slightly volatile Reconciled Depreciation 1.5 K 1.7 K 1.9 K Slightly volatile
Cadrenal Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Change In Cash 3.7 M 1.9 M 937.6 K Slightly volatile Change In Working Capital 2.3 M 2.2 M 843.2 K Slightly volatile Depreciation 1.9 K 2.2 K 1.4 K Slightly volatile Capital Expenditures 4.5 K 7.5 K 3.2 K Slightly volatile Change To Operating Activities 177 K 199.2 K 217.4 K Slightly volatile Total Cash From Financing Activities 8.1 M 10.3 M 3.3 M Slightly volatile End Period Cash Flow 6.8 M 11.5 M 2.2 M Slightly volatile Change To Netincome 4.2 M 4.7 M 5.2 M Slightly volatile Change To Liabilities 353.4 K 397.5 K 433.9 K Slightly volatile Stock Based Compensation 1.2 M 1.6 M 833.4 K Slightly volatile Issuance Of Capital Stock 6.8 M 4.6 M 10.8 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Average Payables 667.9 K 751.4 K 820.2 K Slightly volatile Capex To Depreciation 2.05 3.13 1.8627 Slightly volatile Payables Turnover 0.0025 0.0028 0.0031 Slightly volatile Cash Per Share 4.78 7.39 1.8005 Slightly volatile Days Payables Outstanding 93.4 K 105.1 K 114.7 K Slightly volatile Income Quality 0.34 0.62 0.2592 Slightly volatile Current Ratio 3.89 3.39 1.6709 Slightly volatile Capex Per Share 0.0036 0.0048 0.0039 Slightly volatile Average Receivables 15.3 K 17.2 K 18.7 K Slightly volatile Interest Debt Per Share 0.0484 0.0509 0.7483 Slightly volatile Debt To Assets 0.0027 0.0029 0.6302 Slightly volatile Days Of Payables Outstanding 93.4 K 105.1 K 114.7 K Slightly volatile Ebt Per Ebit 1.67 1.12 2.1862 Slightly volatile Quick Ratio 3.89 3.39 1.6709 Slightly volatile Cash Ratio 3.71 3.36 1.2519 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.1 1.15 1.0155 Slightly volatile Debt Ratio 0.0027 0.0029 0.6302 Slightly volatile
Cadrenal Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 27.6 M 20.3 M 41.1 M Slightly volatile Enterprise Value 8.4 M 8.8 M 38.7 M Slightly volatile

Cadrenal Fundamental Market Drivers

Cadrenal Upcoming Events

About Cadrenal Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cadrenal Therapeutics is a strong investment it is important to analyze Cadrenal Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cadrenal Therapeutics' future performance. For an informed investment choice regarding Cadrenal Stock, refer to the following important reports:

How To Invest In Cadrenal Details

Is Cadrenal Stock a good investment? Details

What is Cadrenal Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details